Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Breast Cancer Research : BCR
|
August 31, 2023
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant
P Neven, P A Fasching, S Chia, et al.
ESMO Open
|
January 21, 2023
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
E de Azambuja, E Agostinetto, M Procter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024]
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2017
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial
A Gennari, Z Sun, U Hasler-Strub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 8, 2021
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium
C Kenis, L Decoster, J Flamaing, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
December 5, 2018
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery
C Quinten, C Kenis, L Decoster, et al.
The Journal of Nutrition, Health & Aging
|
January 6, 2016
A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators
C Kenis, P Heeren, L Decoster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Breast Cancer Research : BCR
|
August 31, 2023
Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant
P Neven, P A Fasching, S Chia, et al.
ESMO Open
|
January 21, 2023
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
E de Azambuja, E Agostinetto, M Procter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024]
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2017
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial
A Gennari, Z Sun, U Hasler-Strub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 8, 2021
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
D J Slamon, P Neven, S Chia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2018
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium
C Kenis, L Decoster, J Flamaing, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
December 5, 2018
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery
C Quinten, C Kenis, L Decoster, et al.
The Journal of Nutrition, Health & Aging
|
January 6, 2016
A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators
C Kenis, P Heeren, L Decoster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
Page
of 9